Plasma Concentrations of sTREM-1 as Markers for Systemic Adverse Reactions in Subjects Treated With Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection

BackgroundA regimen of once-weekly rifapentine plus isoniazid for 3 months (3HP) is an effective treatment for subjects with latent tuberculosis infection; however, no reliable biomarker exists for predicting systemic adverse reactions (SARs) to 3HP treatment.MethodsThis prospective, multi-center st...

Full description

Bibliographic Details

Published in:	Frontiers in Microbiology
Main Authors:	Tsai-Yu Wang, Jia-Yih Feng, Chin-Chung Shu, Susan Shin-jung Lee, Chung-Yu Chen, Yu-Feng Wei, Chih-Bin Lin, Wei-Chang Huang, Wei-Juin Su, Shu-Min Lin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Subjects:	exacerbation sTREM-1 sTREM-2 LTBI tuberculosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2022.821066/full